Cory berkland - Introduction. Head and neck cancers (HNCs) are the sixth most common cancer in people worldwide with over 630,000 new diagnoses each year and with an estimated incidence rate of 65,000 in the United States alone 1.HNCs are categorized based on the anatomical sites where they originate, such as the oral cavity (lips, tongue, gums, hard palate, floor of the mouth), nasal cavity and paranasal ...

 
Cory Berkland, Chemical & Petroleum Engineering, and Pharmaceutical Chemistry; Donna Ginther, Economics; 2011. Brian Blagg, Medicinal Chemistry; Derrick Darby, Philosophy; Patricia Hawley, Psychology; Bangere Purnaprajna, Mathematics News. Four researchers named winners of University Scholarly Achievement Award for 2023(03/28/2023). Dura lube catalytic converter cleaner

Abstract. Lung surfactant is crucial for optimal pulmonary function throughout life. An absence or deficiency of surfactant can affect the surfactant pool leading to respiratory distress. Even if the coupling between surfactant dysfunction and the underlying disease is not always well understood, using exogenous surfactants as replacement is ...Dr. Hartwell obtained her PhD in biomolecular engineering with Cory Berkland at the University of Kansas as a Madison and Lila Self Graduate Fellow. Her doctoral research focused on developing an antigen-specific immunotherapy to treat multiple sclerosis while determining cellular and molecular mechanisms of tolerance.LAWRENCE — Cory Berkland might not be the first person you’d guess would help to create what has become a multimillion-dollar company. The distinguished professor, appointed in the departments of Pharmaceutical Chemistry and Chemical & Petroleum Engineering at the University of Kansas, grew up on a pig farm in Iowa, …Cory Berkland Co-founder and Chief Executive Officer at Bond Biosciences Solon E. Summerfield Distinguished Professor at The University of Kansas 3ySentinel lymph node (SLN) mapping has been widely used to predict the metastatic spread of primary tumor to regional lymph nodes in clinical practice. In this research, a new near-infrared (NIR)-emitting polymer nanogel (NIR-PNG) having a hydrodynamic diameter of about 30 nm, which is optimal for lymph node uptake, was developed. The NIR-emitting polymer nanoprobes were designed and ...PRECLINICAL STUDY The CCL2 chemokine is a negative regulator of autophagy and necrosis in luminal B breast cancer cells Wei Bin Fang • Min Yao • Iman Jokar • Nabil Alhakamy • Cory Berkland • Jin Chen • Dana Brantley-Sieders • Nikki Cheng Received: 4 December 2014/Accepted: 24 February 2015/Published online: 6 March 2015Joe Scherrer. Executive Director, Henry Edwin Sever Institute Director, Cybersecurity Strategic Initiative Program Director, Graduate Studies in Cybersecurity Management.Fang WB, Yao M, Jokar I, Alhakamy N, Berkland C, Chen J, Brantley-Sieders D, Cheng N. The CCL2 chemokine is a negative regulator of autophagy and necrosis in luminal B breast cancer cells. Breast Cancer Res Treat.Cory Berkland; jenn-tai liang; The disclosure is directed to polyelectrolyte complex nano (73) Assignees: University of Kansas, Lawrence, KS particles that can be used to deliver agents deep into ...Cory Berkland, CEO [email protected] Release Summary Bond's clinical lead, BBI-001, is designed to rapidly and selectively bind dietary iron to reduce iron absorption in patients with iron overload.The long-term objective of this application is to deliver a unique biomaterial that can easily be molded into place by a surgeon, and will resorb as it induces rapid tissue regeneration. Toward this o...J. Daniel Griffin, Martin A. Leon, Jean R. Salash, Michael Shao, Brittany L. Hartwell, Chad J. Pickens, Joshua O. Sestak, Cory Berkland. Acute B-Cell Inhibition by Soluble Antigen Arrays Is Valency-Dependent and Predicts Immunomodulation in Splenocytes. Biomacromolecules 2019, 20 (5) , 2115-2122.Introduction. Hollow particles, also referred to as capsules or vesicles, are generating interest in industry as well as scientific research. Many active ingredients have been formulated within a capsule core to protect them from the surrounding environment and/or to facilitate sustained release including; adhesives, agrochemicals, catalysts, living cells, flavor oils, pharmaceuticals ...How it works: Cory Berkland, Ph.D., professor at the University of Kansas, is a serial entrepreneur, co-founding Orbis Biosciences, Savara Pharmaceuticals and Orion Biosciences, as well as co-developing several technologies with industry partners. In late 2012, IAMI invested in novel polymer technology discovered by Dr. Berkland with the intent ...El-Gendy N, Berkland C. Combination chemotherapeutic dry powder aerosols via controlled nanoparticle agglomeration. Pharm Res. 2009; 26:1752-1763. [PMC free article] [Google Scholar] El-Gendy N, et al. Budesonide nanoparticle agglomerates as dry powder aerosols with rapid dissolution. J Pharm Sci. 2009; 98:2731-2746.Hyaluronic acid (HA) is a naturally occurring biodegradable polymer with a variety of applications in medicine, including scaffolding for tissue engineering, dermatological fillers and viscosupplementation for osteoarthritis treatment. HA is available in most connective tissues in body fluids such as synovial fluid and the vitreous humor of …Integrated Science Building (ISB) 1567 Irving Hill Road, Room 1140 Lawrence, KS 66045 [email protected] 785-864-4670Cory Berkland, CEO [email protected]. Release Summary. Phase Ia/b will assess the safety of BBI-001 and test the ability of BBI-001 to prevent iron uptake from food. Contacts.J Pharm Innov (2010) 5:70-71 DOI 10.1007/s12247-010-9084- EDITORIAL Cory Berkland Published online: 16 July 2010 # Springer Science+Business Media, LLC 2010 In the pharmaceutical community, nanotechnology has that particles with a diameter larger than about 10 nm may become the flavor of the day for anything with a size or persist in circulation due to exclusion from renal filtration ...Cory Berkland. The University of Kansas. 在 ku.edu 的电子邮件经过验证. Drug DeliveryFormulationControlled Release. 文章引用次数开放获取的出版物 ...Abdulgader A. Baoum1 and Cory J. Berkland1,2,* 1Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS ... Baoum and Berkland Page 3 J Pharm Sci. Author manuscript; available in PMC 2014 October 23. NIH-PA Author Manuscript. gene delivery in vivo28,39-41. One approach for overcoming this limitation was to link theKhia Preston Director Of Operations at The UPS Store - #3263, 2473, 3354, 3723, 1152, 3443, 0754Cory Berkland PhD, VP Strategic Development. Kingdom Capital Portfolio Advisors. View fullsize.This article is cited by 2 publications. J. Daniel Griffin, Martin A. Leon, Jean R. Salash, Michael Shao, Brittany L. Hartwell, Chad J. Pickens, Joshua O. Sestak, Cory Berkland. Acute B-Cell Inhibition by Soluble Antigen Arrays Is Valency-Dependent and Predicts Immunomodulation in Splenocytes.Fang WB, Yao M, Jokar I, Alhakamy N, Berkland C, Chen J, Brantley-Sieders D, Cheng N. The CCL2 chemokine is a negative regulator of autophagy and necrosis in luminal B breast cancer cells. Breast Cancer Res Treat.Recently, lymphocyte function-associated antigen-1 (LFA-1), a primary cell adhesion molecule, has also been investigated for targeting nanoparticles to human leukemic cell line ( 30, 32 ). Lima et al. reported that certain leukemic cells expressed 5-fold more LFA-1 than normal leukocytes ( 32 ). Since LFA-1 is expressed only on leukocytes, it ...Brittany L Hartwell 1 , Chad J Pickens 2 , Martin Leon 3 , Cory Berkland 1 2 4 Affiliations 1 Bioengineering Graduate Program, University of Kansas 1520 West 15th Street, Lawrence, Kansas 66045, United States. 2 Department of Pharmaceutical Chemistry, University of Kansas 2095 Constant Avenue ...1. Introduction. Injectable scaffolds have received attention due to their potential for avoiding the invasive surgery typically required for tissue implantation. 1 From a clinical perspective, the use of injectable materials is an attractive alternative to surgery as it reduces the risk of infection, scar formation, patient discomfort and the cost of treatment. 2 Injectable scaffolds may be ...Qingting Hu, 1 Megan Myers, 1 Wei Fang, 1 Min Yao, 1 Gage Brummer, 1 Justin Hawj, 1 Curtis Smart, 1 Cory Berkland, 2 and Nikki Cheng 1, 3, * Qingting Hu 1 Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USAThe potential of this polymer for siRNA delivery was assessed. This triblock copolymer formed nanocapsules with high siRNA encapsulation efficiency that protected siRNA from degradation in serum. Capsules were pH-sensitive and deformed when pH decreased below 6. In vitro RNAi evaluation demonstrated that the capsules are capable of delivering ...Dr. Cory Berkland Solon E. Summerfield Distinguished Professor School of Engineering, School of Pharmacy Chemical and Petroleum Engineering, Pharmaceutical Chemistry RESEARCH INTERESTS Antigen-specific immunotherapies, sequestering cells to combat autoimmunity, autoimmunity and tolerance reintroduction, targeted drug delivery, and gene delivery.Nanoparticles Targeting Dendritic Cell Surface Molecules Effectively Block T cell Conjugation and Shift Response Chuda Chittasupho1, Laura Shannon2, Teruna J. Siahaan1, Charlotte M. Vines2, and Cory Berkland1,3 1Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, 66047 2Department of Microbiology, Molecular Genetics and Immunology, University of Kansas MedicalCory Berkland; Content type: Research Article Published: 06 September 2014; Pages: 1185 - 1193; This is part of 1 collection: Theme: Nanoparticles in Vaccine Delivery; A Therapeutic Microparticle-Based Tumor Lysate Vaccine Reduces Spontaneous Metastases in Murine Breast Cancer Authors (first, second and last of 5) ...INTRODUCTION. Investigations into the molecular processes involved in antigen recognition have led to new approaches in the design and administration of vaccines (1, 2).Traditionally, vaccines generate a robust immune response to a particular antigen by adsorbing the antigen to an alum particle surface (3-5).Though individual alum particles are quite small (10-50 nm), in solution they form ...Todd Berkland Work Experience and Education. According to ZoomInfo records, Todd Berkland`s professional experience began in 2000. Since then Todd has changed 4 companies and 3 roles. Currently, Todd Berkland works as a Vice President, Business Development & Acquisitions at Wrench Group.Hartwell BL; Pickens CJ; Leon M; Berkland C, Multivalent Soluble Antigen Arrays Exhibit High Avidity Binding and Modulation of B Cell Receptor-Mediated Signaling to Drive Efficacy against Experimental Autoimmune Encephalomyelitis. Biomacromolecules 2017, 18 (6), 1893–1907. [PMC free article] [Google Scholar]Cory Berkland Chronic iron overload is a serious condition that develops as a consequence of long-term accumulation of iron, eventually overwhelming iron storage systems and causing oxidative ... Sentinel lymph node (SLN) mapping has been widely used to predict the metastatic spread of primary tumor to regional lymph nodes in clinical practice. In this research, a new near-infrared (NIR)-emitting polymer nanogel (NIR-PNG) having a hydrodynamic diameter of about 30 nm, which is optimal for lymph node uptake, was developed. The NIR-emitting …Cory Berkland. The Berkland Lab investigates pharmaceuticals and biomaterials. They aim to understand the transport of pharmaceuticals as a function of physical and chemical properties. Biomaterials are also investigated for applications in regenerative medicine. Faculty Profile. Berkland Research Lab.May 4, 2017 · LAWRENCE — Cory Berkland might not be the first person you’d guess would help to create what has become a multimillion-dollar company. The distinguished professor, appointed in the departments of Pharmaceutical Chemistry and Chemical & Petroleum Engineering at the University of Kansas, grew up on a pig farm in Iowa, studied chemical engineering at the undergraduate and graduate levels and ... Cory Berkland. Solon E. Summerfield Distinguished Professor. PHARMACEUTICAL CHEMISTRY. Contact Info. 785-864-1455. Multidisciplinary Research Building, Room …Dr. Hartwell obtained her PhD in biomolecular engineering with Cory Berkland at the University of Kansas as a Madison and Lila Self Graduate Fellow. Her doctoral research focused on developing an antigen-specific immunotherapy to treat multiple sclerosis while determining cellular and molecular mechanisms of tolerance.11‏/02‏/2023 ... Curt Berkland passed away on February 11, 2023 in Emmetsburg, Iowa. Funeral Home Services for Curt are being provided by Martin-Mattice ...01‏/02‏/2010 ... ... Cory Berkland, Ph.D., who, with George Laurence, invented the company's NanoCluster technology in his laboratory at the University of Kansas ...Cory Berkland; jenn-tai liang; The disclosure is directed to polyelectrolyte complex nano (73) Assignees: University of Kansas, Lawrence, KS particles that can be used to deliver agents deep into ...Number of Employee Profiles 2. Bond Biosciences has 2 current employee profiles, including Co-founder and Chief Scientific Officer Cory Berkland. Cory Berkland Co-founder and Chief Scientific Officer.The company's lead candidate, BBI-001, is an iron chelator for the treatment of hereditary hemochromatosis. Bond joins the St. Louis ecosystem after licensing technology originally developed at the University of Kansas. Bond was founded by St. Louisan and serial entrepreneur Cory Berkland, PhD.Qingting Hu, 1 Megan Myers, 1 Wei Fang, 1 Min Yao, 1 Gage Brummer, 1 Justin Hawj, 1 Curtis Smart, 1 Cory Berkland, 2 and Nikki Cheng 1, 3, * Qingting Hu 1 Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USAAU - Berkland, Cory. AU - Pack, Daniel W. AU - Kim, Kyekyoon. N1 - Funding Information: We would like to thank Dr. Kevin Kim's research group for the FFESS set-up for polymer spraying experiments, especially Dr. HoChul Kang. The tungsten needles used in this work were donated by Point Technologies. Scanning electron micrographs were attained at ...Dr. Kenneth L. Caldwell is a Orthopedist in Pasadena, TX. Find Dr. Caldwell's phone number, address, insurance information, hospital affiliations and more.16‏/05‏/2014 ... The principal investigator from the University of Kansas for the project is Cory Berkland, KU professor of chemical and petroleum engineering ...Prostate-targeted biodegradable nanoparticles loaded with androgen receptor silencing constructs eradicate xenograft tumors in mice Jun Yang1,2, Sheng-Xue Xie3, Yiling Huang1,4, Min Ling1, Jihong Liu2, Yali Ran1, Yanlin Wang4, J Brantley Thrasher1, Cory Berkland3, and Benyi Li*,1,4 1Department of Urology, The University of Kansas Medical Center, Kansas City, KS 66160, USACory Berkland [email protected] Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047. Department of Chemical and Petroleum Engineering, The University of Kansas, Lawrence, Kansas 66047. Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047===Search for more papers by this authorSentinel lymph node (SLN) mapping has been widely used to predict the metastatic spread of primary tumor to regional lymph nodes in clinical practice. In this research, a new near-infrared (NIR)-emitting polymer nanogel (NIR-PNG) having a hydrodynamic diameter of about 30 nm, which is optimal for lymph node uptake, was developed. The NIR-emitting …Joshua O Sestak 1 , Bradley P Sullivan 1 , Sharadvi Thati 1 , Laura Northrup 1 , Brittany Hartwell 2 , Lorena Antunez 1 , M Laird Forrest 1 , Charlotte M Vines 3 , Teruna J Siahaan 1 , Cory Berkland 4Jim Berkland. James O. Berkland (July 31, 1930 - July 22, 2016) was an American geologist [1] who controversially claimed to be able to predict earthquakes, including the 1989 Loma Prieta earthquake and 1994 Northridge Earthquake [2] and who popularized the idea that some people are earthquake sensitive. He was profiled in a popular 2006 book ...Nabil A Alhakamy 1 , David T Curiel 2 , Cory J Berkland 3 Affiliations 1 Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia; ... University of Kansas, Lawrence, KS 66047, USA. Electronic address: [email protected]. PMID: 33781953 DOI: 10.1016/j.drudis.2021.03.021 AbstractBy Akihisa Nonoyama, Ph.D., Nathan Dormer, Ph.D., and Cory Berkland, Ph.D., Adare Pharma Solutions Quetiapine is an antipsychotic drug used for the treatment of schizophrenia, bipolar disorder and depression and is currently marketed as a QD tablet. An alternate presentation of the drug in the form of controlled release microspheres would ...คณะเทคนิคการแพทย์ มหาวิทยาลัยเชียงใหม่ 110 ถนนอินทวโรรส ตำบล ...Practical Considerations, Challenges, and Limitations of Bioconjugation via Azide-Alkyne Cycloaddition Chad J. Pickens1, Stephanie N. Johnson1, Melissa M. Pressnall1, Martin A. Leon2, and Cory J. Berkland1,2 1Department of Pharmaceutical Chemistry, University of Kansas, 2095 Constant Avenue, Lawrence, Kansas 66047, USAHartwell BL; Pickens CJ; Leon M; Berkland C, Multivalent Soluble Antigen Arrays Exhibit High Avidity Binding and Modulation of B Cell Receptor-Mediated Signaling to Drive Efficacy against Experimental Autoimmune Encephalomyelitis. Biomacromolecules 2017, 18 (6), 1893–1907. [PMC free article] [Google Scholar]Brian T. Andrews, Scott Barbay, Sheila Tsau, Cory Berkland, Jakob M. Townsend, Michael S. Detamore, Chad A. Tuchek, Randolph J. Nudo Effects of distance and transport method on intervention and ...Christian Pharmacists Fellowship International (CPFI) unites pharmacists and pharmacy students working to incorporate their faith into the pharmacy profession. CPFI has chapters throughout the United States and offers members opportunities for community service, short or long term mission trips, bible studies and an annual national conference.Nashwa El-Gendy1,3, Warangkana Pornputtapitak1, and Cory Berkland1,2,* 1Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS 66047. ... Fax: (001) 785- 864- 1454. [email protected]. Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to ourBerkland, Cory J. Publisher. Nature Publishing Group. Type. Article. Article Version. Scholarly/refereed, publisher version. Metadata Show full item record. Abstract. Autoimmune diseases such as multiple sclerosis (MS) are typified by the misrecognition of self-antigen and the clonal expansion of autoreactive T cells. Antigen-specific ...Cory Berkland The University of Kansas Lawrence, KS. Joel Bernstein New York University Abu Dhabi Abu Dhabi, United Arab Emirates. Michael Blaber Florida State University Tallahassee, FL. Robin H. Bogner University of Connecticut Storrs, CT. Kathleen MK Boje State University of Buffalo Amherst, NY.Title: PLGA nanoparticle-peptide conjugate effectively targets intercellular cell-adhesion molecule-1: Authors: Na Zhang Chuda Chittasupho Chadarat DuangratProf. Berkland is a co-founder of Orbis Biosciences, Savara Pharmaceuticals, Bond Biosciences and Orion BioScience. He is also a co-developer of several technologies with industrial partners. He...Cory Berkland is a Professor in the Department of Pharmaceutical Chemistry and in the Department of Chemical Engineering at The University of Kansas. He received MS and PhD degrees from the Department of Chemical and Biomolecular Engineering at the University of Illinois in Urbana-Champaign and a BS degree in Chemical Engineering from Iowa ...LAWRENCE — Cory Berkland might not be the first person you'd guess would help to create what has become a multimillion-dollar company. The distinguished professor, appointed in the departments of Pharmaceutical Chemistry and Chemical & Petroleum Engineering at the University of Kansas, grew up on a pig farm in Iowa, studied chemical engineering at the undergraduate and graduate levels and ...Singkome Tima; Siriporn Okonogi; Chadarat Ampasavate; Chad Pickens; Cory Berkland; Songyot Anuchapreeda: 18-May-2016: Down-regulatory mechanism of mammea E/BB from Mammea siamensis seed extract on Wilms' Tumor 1 expression in K562 cellsRecently, lymphocyte function-associated antigen-1 (LFA-1), a primary cell adhesion molecule, has also been investigated for targeting nanoparticles to human leukemic cell line ( 30, 32 ). Lima et al. reported that certain leukemic cells expressed 5-fold more LFA-1 than normal leukocytes ( 32 ). Since LFA-1 is expressed only on leukocytes, it ...Course Search. Search class sections | Online courses. Library SearchCory Berkland. Solon E. Summerfield Distinguished Professor. Department of Pharmaceutical Chemistry. Contact Info. [email protected]. 785-864-1455. …Dr. Hartwell obtained her Ph.D. in biomolecular engineering with Cory Berkland at the University of Kansas as a Madison and Lila Self Graduate Fellow. Her doctoral research focused on developing an antigen-specific immunotherapy to treat multiple sclerosis while determining cellular and molecular mechanisms of tolerance.Cory Berkland's interest in business developed during his graduate engineering studies and blossomed into two companies, within which he still plays an active role. While Berkland was working on his Ph.D. in chemical and biological engineering at the University of Illinois, ...03‏/04‏/2023 ... ... Cory J Berkland. Affiliations. 1 Bioengineering Program, The University of Kansas, Lawrence, Kansas 66045, United States. 2 HylaPharm ...Chad J Pickens 1 , Stephanie N Johnson 1 , Melissa M Pressnall 1 , Martin A Leon 2 , Cory J Berkland 1 2 3 Affiliations 1 Department of Pharmaceutical Chemistry , University of Kansas , 2095 Constant Avenue , Lawrence , Kansas 66047 , United States.Jun Yang, 1, 2 Sheng-Xue Xie, 3 Yiling Huang, 1, 4 Min Ling, 1 Jihong Liu, 2 Yali Ran, 1 Yanlin Wang, 4 J Brantley Thrasher, 1 Cory Berkland, 3 and Benyi Li *, 1, 4 Jun Yang 1 Department of Urology, The University of Kansas Medical Center, Kansas City, KS 66160, USAA Few Early Lessons in Entrepreneurship. Cory Berkland, Ph.D. Friday, September 1, 2017. 1:30 P.M.. Rawl Engineering Practice Facility, Room 200. Cory ...Ruolin Lu, 1 Chad Groer, 2 Peter A. Kleindl, 1 K. Ryan Moulder, 1 Aric Huang, 1 Jordan R. Hunt, 1 Shuang Cai, 1, 2 Daniel J. Aires, 2, 3 Cory Berkland, 1 and Laird Forrest 1, 2, * Ruolin Lu 1 Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KansasCory Berkland The University of Kansas Lawrence, KS. Joel Bernstein New York University Abu Dhabi Abu Dhabi, United Arab Emirates. Michael Blaber Florida State University Tallahassee, FL. Robin H. Bogner University of Connecticut Storrs, CT. Kathleen MK Boje State University of Buffalo Amherst, NY.Cory Berkland. [email protected]; Department of Chemical & Petroleum Engineering, University of Kansas, Lawrence, Kansas 66047. Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66047. Department of Chemical & Petroleum Engineering, University of Kansas, Lawrence, Kansas 66047===Search for more papers by this authorDr. Cory Berkland Solon E. Summerfield Distinguished Professor School of Engineering, School of Pharmacy Chemical and Petroleum Engineering, Pharmaceutical Chemistry RESEARCH INTERESTSAntigen-specific immunotherapies, sequestering cells to combat autoimmunity, autoimmunity and tolerance reintroduction, targeted drug delivery, and gene delivery.RESEARCH WEBSITE CONTACT INFO [email protected] ... Contact Info [email protected] 785-864-1455 Multidisciplinary Research Building, Room 320E Research — In recent history, through the merger of engineering and biological sciences, biotechnology has pressed toward improving methods for regenerating tissues, developing biosensors, and effectively delivering therapeutic agents.Amir Fakhari1 and Cory Berkland1,2,3,* 1Bioengineering Graduate Program, University of Kansas 2Department of Pharmaceutical Chemistry, School of Pharmacy, ... [email protected]. Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to ourCory Berkland Mario Rivera Kate ESHELMAN Jian QIAN Nashwa EL-GENDY Original Assignee The University Of Kansas Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) 2014-10-10 Filing date 2015-10-08 Publication ...Cory Berkland is a professor of pharmaceutical chemistry and chemical and petroleum engineering at the University of Kansas. (Berkland Tr. 593) The Court recognized Dr. Berkland as an expert in the preparation and analysis of pharmaceutical formulations. (Id. at 594) B. Defendants' Experts.Cory Berkland View For the in vitro release experiment, 50 µl of UM-3003 adsorbed alhydrogel formulation was mixed with 500 µl of adjuvant-free human plasma in a closed glass vial at 37 °C and ...Cory Berkland Songyot Anuchapreeda: Authors: Singkome Tima Siriporn Okonogi Chadarat Ampasavate Chad Pickens Cory Berkland Songyot Anuchapreeda: Keywords: Pharmacology, Toxicology and Pharmaceutics: Issue Date: 1-Dec-2016: Abstract:

What We Do. Our lab works at the interface of medicine and engineering with an emphasis on precisely controlling the physical and chemical properties of particles and biomaterials. The lab environment fosters multidisciplinary interaction between graduate and undergraduate researchers from the departments of Chemical and Petroleum Engineering .... All bills paid second chance apartments in irving tx

cory berkland

Abstract: Particles for delivery of active ingredients formed from an active ingredient and a hydrophobic matrix, as well as methods for making such particles. Type: Grant. Filed: August 16, 2019. Date of Patent: February 14, 2023. Assignee: ADARE PHARMACEUTICALS USA, INC. Inventors: Cory Berkland, Milind Singh.Corporate Faith - 2023 Business Speakers Series - Cory Berkland. Mon, Aug 14, 6:00 PM. Undivided Experience Center • Chesterfield, MO. Free. Save Corporate Faith - 2023 Business Speakers Series - Cory Berkland to your collection.Cory Berkland is a professor of pharmaceutical chemistry and chemical and petroleum engineering at the University of Kansas. (Berkland Tr. 593) The Court recognized Dr. Berkland as an expert in the preparation and analysis of pharmaceutical formulations. (Id. at 594) B. Defendants' Experts."Soft" Calcium Crosslinks Enable Highly Efficient Gene Transfection Using TAT Peptide Abdulgader Baoum1, Sheng-Xue Xie1, Amir Fakhari2, and Cory Berkland1,3,4 1Department of Pharmaceutical Chemistry, The University of Kansas, 2030 Becker Drive, Lawrence, Kansas 66047, USA 2Department of Bioengineering, The University of Kansas, 2030 Becker Drive, Lawrence, KansasThe most recent tenant is Cheryl Kootman.Past residents include Jodi Berkland, Cory Berkland, Marc Kootman, Branch Metal Processing and Jonathan Kootman.FastPeopleSearch results provide address history, property records, and contact information for current and previous tenants.So Cory Berkland and colleagues set out to find new kinds of pharmaceuticals to fight weight gain. Targeting the body's process of absorbing fat, the researchers designed a class of polymers that capture fat particles called micelles in the intestines so they can't be digested. Instead, they pass through the gut and are excreted.Abdulgader Baoum1, Sheng-Xue Xie1, Amir Fakhari2, and Cory Berkland1,3,4 1Department of Pharmaceutical Chemistry, The University of Kansas, 2030 Becker Drive, Lawrence, Kansas 66047, USA 2Department of Bioengineering, The University of Kansas, 2030 Becker Drive, Lawrence, Kansas 66047, USAIntroduction. Advancements in treating autoimmune diseases such as multiple sclerosis (MS) have been made by enhancing our understanding of the molecular processes involved in disease progression. 1,2 The complexity of immune responses and the heterogeneous nature of immune cells complicate the design of therapeutics. In the case …Hartwell BL; Pickens CJ; Leon M; Berkland C, Multivalent Soluble Antigen Arrays Exhibit High Avidity Binding and Modulation of B Cell Receptor-Mediated Signaling to Drive Efficacy against Experimental Autoimmune Encephalomyelitis. Biomacromolecules 2017, 18 (6), 1893-1907. [PMC free article] [Google Scholar]Cory Berkland, PhD. WIZARD FEATURES. © 2023 DeKosky Lab.Raj K Bhala. Brenneisen Distinguished Professor. Raymond F. Rice Distinguished Professor. View full profile.Nanoparticles Targeting Dendritic Cell Surface Molecules Effectively Block T cell Conjugation and Shift Response Chuda Chittasupho1, Laura Shannon2, Teruna J. Siahaan1, Charlotte M. Vines2, and Cory Berkland1,3 1Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, 66047 2Department of Microbiology, Molecular Genetics and Immunology, University of Kansas MedicalLymphatic trafficking kinetics and near-infrared imaging using star polymer architectures with controlled anionic character Taryn R. Bagby1, Shuang Cai1, Shaofeng Duan1, Qiuhong Yang1, Sharadvi Thati1, Cory Berkland1, Daniel J. Aires2, and M. Laird Forrest1,* 1 Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 2 Division of Dermatology, Dept. of Internal Medicine ...Raj K Bhala. Brenneisen Distinguished Professor. Raymond F. Rice Distinguished Professor. View full profile.PRECLINICAL STUDY The CCL2 chemokine is a negative regulator of autophagy and necrosis in luminal B breast cancer cells Wei Bin Fang • Min Yao • Iman Jokar • Nabil Alhakamy • Cory Berkland • Jin Chen • Dana Brantley-Sieders • Nikki Cheng Received: 4 December 2014/Accepted: 24 February 2015/Published online: 6 March 2015Cory Berkland, PhD. CEO, BOND BIOSCIENCES. Saint Louis, Missouri, United States. Dr. Berkland serves as the Chairman of the Board, President, Chief Executive Officer ….

Popular Topics